Pharmaceutical companies settle AWP litigation
Pharma Compliance Alert, March 12, 2008
All but two pharmaceutical companies have agreed to pay $125 million to settle allegations they intentionally inflated reports of the average wholesale prices on certain prescription drugs, according to a press release from Seattle-based law firm Hagens Berman, co-lead counsel in the case.
The settlement resolves allegations from a lawsuit filed in 2002 by consumers and insurance companies. Under the terms of the settlement, third-party payers will receive 82.5% of the settlement and the remaining 17.5 % will go to consumers.
The defendants included in the settlement are:
- Abbott Laboratories
- Amgen Inc.
- Aventis Pharmaceuticals Inc.
- Hoechst Marion Roussel
- BaxterHealthcare Corp.
- Baxter International Inc.
- Bayer Corporation
- Dey, Inc.
- Fujisawa Healthcare, Inc.
- Fujisawa USA, Inc
- Immunex Corporation
- Pharmacia Corporation
- Pharmacia & Upjohn LLC
- Sicor, Inc.
- Gensia, Inc. and Gensia Sicor Pharmaceuticals, Inc.
- Watson Pharmaceuticals, Inc
- ZLB Behring, L.L.C.
AstraZeneca and Bristol-Myers Squibb were not part of the settlement and will instead go to trial, according to Hagens Berman.
Comments
0 comments on “Pharmaceutical companies settle AWP litigation ”
Related Products
-
ePharm5 InDepth
EPharm5 e-mail newsletter delivers the top 5 developments in pharma business innovation, with original research, interviews...
-
Big Pharma Performance Before, During and Beyond the Global Recession
This report assesses the performance of the leading 15 pharmaceutical companies up to, during and beyond the recent global...
Most Popular
- Articles
-
- Q/A: Volume requirement for reporting hydration services
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Catch up on what's new with injections and infusions
- Topic: CMS, OESS post new security compliance review information, checklist
- What does case-mix index mean to you?
- QA:Coding multiple initial infusions
- Capturing all necessary codes for IUD insertion and removal can be challenging
- News and briefs: Oklahoma Osteopathic Association against residency bill change
- OB services: Coding inside and outside of the package
- HIPAA Q&A: Level of encryption needed for email
- E-mailed
-
- Q/A: Volume requirement for reporting hydration services
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Catch up on what's new with injections and infusions
- New conflicts of interest create new challenges
- Joint Commission Center announces handoff communication solutions
- Inside best practice: Reduce patient falls with a stoplight
- Identify modifiable risk factors to prevent patient falls
- Hospitalist-surgeon comanagement has no effect on outcomes
- HIPAA Q&A: Level of encryption needed for email
- Case Management Monthly, June 2012
- Searched